Article
Targeting CK2 in cancer: a valuable strategy or a waste of time?
29 Oct 2021
Abstract excerpt
CK2 is a protein kinase involved in several human diseases (ranging from neurological and cardiovascular diseases to autoimmune disorders, diabetes, and infections, including COVID-19), but its best-known implications are in cancer, where it is considered a pharmacological target. Several CK2 inhibitors are available and clinical trials are underway in different cancer types. Recently, the suitability of CK2 as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
